Shree Hari Chemicals Export（524336）株式概要Shree Hari Chemicals Export Limited社は、H-酸と染料中間体の製造、輸出、供給をインド国内外で行っている。 詳細524336 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績6/6財務の健全性3/6配当金0/6報酬株価収益率（ 17.3 x） Indian市場（ 22.5 x）を下回っています。過去1年間で収益は264.3%増加しました リスク分析過去1年間で株主の希薄化は大幅に進んだ 多額の負債を抱えている 意味のある時価総額がありません ( ₹2B )Indian市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見る524336 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW474,563 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA474,563 investors already sharing narrativesYour Fair Value₹Current Price₹178.95146.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-156m5b2016201920222025202620282031Revenue ₹5.4bEarnings ₹293.8mAdvancedSet Fair ValueView all narrativesShree Hari Chemicals Export Limited 競合他社Ducol Organics And ColoursSymbol: NSEI:DUCOLMarket cap: ₹1.6bIndian PhosphateSymbol: NSEI:IPHLMarket cap: ₹1.6bAmeenji RubberSymbol: BSE:544555Market cap: ₹2.1bKesar PetroproductsSymbol: BSE:524174Market cap: ₹1.6b価格と性能株価の高値、安値、推移の概要Shree Hari Chemicals Export過去の株価現在の株価₹178.9552週高値₹190.0052週安値₹87.65ベータ0.221ヶ月の変化31.53%3ヶ月変化55.34%1年変化66.62%3年間の変化292.43%5年間の変化207.47%IPOからの変化2,103.82%最新ニュースReported Earnings • 1hFirst quarter 2027 earnings released: EPS: ₹9.41 (vs ₹3.39 loss in 1Q 2026)First quarter 2027 results: EPS: ₹9.41 (up from ₹3.39 loss in 1Q 2026). Revenue: ₹556.3m (up 129% from 1Q 2026). Net income: ₹59.2m (up ₹76.0m from 1Q 2026). Profit margin: 11% (up from net loss in 1Q 2026). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (9.0% average weekly change). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.96b market cap, or US$20.6m).お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2027 Results on Aug 14, 2026Shree Hari Chemicals Export Limited announced that they will report Q1, 2027 results on Aug 14, 2026Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹164, the stock trades at a trailing P/E ratio of 45.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 260% over the past three years.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹132, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.6m).最新情報をもっと見るRecent updatesReported Earnings • 1hFirst quarter 2027 earnings released: EPS: ₹9.41 (vs ₹3.39 loss in 1Q 2026)First quarter 2027 results: EPS: ₹9.41 (up from ₹3.39 loss in 1Q 2026). Revenue: ₹556.3m (up 129% from 1Q 2026). Net income: ₹59.2m (up ₹76.0m from 1Q 2026). Profit margin: 11% (up from net loss in 1Q 2026). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (9.0% average weekly change). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.96b market cap, or US$20.6m).お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2027 Results on Aug 14, 2026Shree Hari Chemicals Export Limited announced that they will report Q1, 2027 results on Aug 14, 2026Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹164, the stock trades at a trailing P/E ratio of 45.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 260% over the past three years.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹132, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.6m).New Risk • May 23New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.27b market cap, or US$13.3m).Reported Earnings • May 18Full year 2026 earnings released: EPS: ₹7.45 (vs ₹11.41 in FY 2025)Full year 2026 results: EPS: ₹7.45 (down from ₹11.41 in FY 2025). Revenue: ₹1.88b (up 33% from FY 2025). Net income: ₹41.2m (down 19% from FY 2025). Profit margin: 2.2% (down from 3.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.お知らせ • May 08Shree Hari Chemicals Export Limited to Report Fiscal Year 2026 Results on May 15, 2026Shree Hari Chemicals Export Limited announced that they will report fiscal year 2026 results on May 15, 2026Valuation Update With 7 Day Price Move • May 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹125, the stock trades at a trailing P/E ratio of 45.8x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 178% over the past three years.Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹2.20 (vs ₹5.91 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.20 (down from ₹5.91 in 3Q 2025). Revenue: ₹447.8m (up 15% from 3Q 2025). Net income: ₹12.2m (down 54% from 3Q 2025). Profit margin: 2.7% (down from 6.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 23Shree Hari Chemicals Export Limited to Report Q3, 2026 Results on Jan 31, 2026Shree Hari Chemicals Export Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Jan 31, 2026New Risk • Dec 06New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 137% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). High level of non-cash earnings (41% accrual ratio). Shareholders have been substantially diluted in the past year (137% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹1.29b market cap, or US$14.3m).Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 37%After last week's 37% share price gain to ₹142, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 163% over the past three years.お知らせ • Nov 07Shree Hari Chemicals Export Limited to Report Q2, 2026 Results on Nov 14, 2025Shree Hari Chemicals Export Limited announced that they will report Q2, 2026 results on Nov 14, 2025New Risk • Sep 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). Market cap is less than US$10m (₹495.5m market cap, or US$5.58m). Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).お知らせ • Aug 18Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2025Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2025, at 15:00 Indian Standard Time.Reported Earnings • Aug 14First quarter 2026 earnings released: ₹3.39 loss per share (vs ₹0.47 profit in 1Q 2025)First quarter 2026 results: ₹3.39 loss per share (down from ₹0.47 profit in 1Q 2025). Revenue: ₹245.3m (down 21% from 1Q 2025). Net loss: ₹16.7m (down ₹18.8m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2026 Results on Aug 13, 2025Shree Hari Chemicals Export Limited announced that they will report Q1, 2026 results on Aug 13, 2025New Risk • May 31New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹729.0m market cap, or US$8.52m).Reported Earnings • May 31Full year 2025 earnings released: EPS: ₹11.41 (vs ₹5.16 in FY 2024)Full year 2025 results: EPS: ₹11.41 (up from ₹5.16 in FY 2024). Revenue: ₹1.42b (up 3.2% from FY 2024). Net income: ₹51.0m (up 122% from FY 2024). Profit margin: 3.6% (up from 1.7% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.お知らせ • May 22Shree Hari Chemicals Export Limited to Report Q4, 2025 Results on May 29, 2025Shree Hari Chemicals Export Limited announced that they will report Q4, 2025 results on May 29, 2025Board Change • Mar 26Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Additional Independent Director Sanjay Gupta was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 25Shree Hari Chemicals Export Limited Announces Cessation of Ekta Sumit Sultania as an Independent DirectorShree Hari Chemicals Export Limited informed that Smt. Ekta Sumit Sultania (DIN: 07134485) retired on completion of her term of office as an Independent Director of the Company on March 25, 2025 and ceased to be the Independent Director of the Company thereafter.Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹151, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 136% over the past three years.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹124, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹5.91 (vs ₹2.33 in 3Q 2024)Third quarter 2025 results: EPS: ₹5.91 (up from ₹2.33 in 3Q 2024). Revenue: ₹392.6m (up 6.2% from 3Q 2024). Net income: ₹26.3m (up 154% from 3Q 2024). Profit margin: 6.7% (up from 2.8% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 04Shree Hari Chemicals Export Limited to Report Q3, 2025 Results on Feb 12, 2025Shree Hari Chemicals Export Limited announced that they will report Q3, 2025 results on Feb 12, 2025Valuation Update With 7 Day Price Move • Dec 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹128, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 113% over the past three years.Reported Earnings • Nov 13Second quarter 2025 earnings released: EPS: ₹5.05 (vs ₹1.83 in 2Q 2024)Second quarter 2025 results: EPS: ₹5.05 (up from ₹1.83 in 2Q 2024). Revenue: ₹366.6m (down 6.1% from 2Q 2024). Net income: ₹22.4m (up 175% from 2Q 2024). Profit margin: 6.1% (up from 2.1% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹99.26, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years.お知らせ • Nov 04Shree Hari Chemicals Export Limited to Report Q2, 2025 Results on Nov 12, 2024Shree Hari Chemicals Export Limited announced that they will report Q2, 2025 results on Nov 12, 2024Buy Or Sell Opportunity • Oct 22Now 20% undervaluedOver the last 90 days, the stock has risen 17% to ₹93.45. The fair value is estimated to be ₹118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Meanwhile, the company has become profitable.Board Change • Sep 12High number of new directorsAdditional Independent Director Sanjay Gupta was the last director to join the board, commencing their role in 2024.New Risk • Aug 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Market cap is less than US$10m (₹443.6m market cap, or US$5.29m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).お知らせ • Aug 29Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2024Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2024, at 13:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹99.76, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 66% over the past three years.お知らせ • Aug 22Shree Hari Chemicals Export Limited announced a financing transactionShree Hari Chemicals Export Limited announced a private placement to issue Compulsorily Convertible Debentures on August 20, 2024. The transaction has been approved by shareholders and is subject to general shareholders of 37 Annual General Meeting of the Company.お知らせ • Aug 15Shree Hari Chemicals Export Limited Approves the Appointment of Vikas Agarwal as Additional Non- Executive DirectorShree Hari Chemicals Export Limited at its board meeting held on August 12, 2024, based on the recommendation of the Nomination and Remuneration Committee, considered and approved the appointment of Shri Vikas Agarwal as an Additional Non- Executive Director of the Company with effect from August 12, 2024 who shall hold office up to the date of the upcoming Annual General Meeting of the Company. Shri Vikas Agarwal is a MBA and Commerce Graduate with over 20 years of experience in polyester business.Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: ₹0.47 (vs ₹0.37 in 1Q 2024)First quarter 2025 results: EPS: ₹0.47 (up from ₹0.37 in 1Q 2024). Revenue: ₹310.0m (up 5.5% from 1Q 2024). Net income: ₹2.08m (up 27% from 1Q 2024). Profit margin: 0.7% (up from 0.6% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Aug 05Shree Hari Chemicals Export Limited to Report Q1, 2025 Results on Aug 12, 2024Shree Hari Chemicals Export Limited announced that they will report Q1, 2025 results on Aug 12, 2024Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹89.21, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 24% over the past three years.Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹5.16 (vs ₹44.54 loss in FY 2023)Full year 2024 results: EPS: ₹5.16 (up from ₹44.54 loss in FY 2023). Revenue: ₹1.43b (up 39% from FY 2023). Net income: ₹22.9m (up ₹221.0m from FY 2023). Profit margin: 1.6% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • May 20Shree Hari Chemicals Export Limited to Report Q4, 2024 Results on May 27, 2024Shree Hari Chemicals Export Limited announced that they will report Q4, 2024 results on May 27, 2024Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹99.34, the stock trades at a trailing P/E ratio of 58.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 62% over the past three years.Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹2.33 (vs ₹21.76 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹2.33 (up from ₹21.76 loss in 3Q 2023). Revenue: ₹372.9m (down 4.8% from 3Q 2023). Net income: ₹10.4m (up ₹107.1m from 3Q 2023). Profit margin: 2.8% (up from net loss in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.お知らせ • Feb 07Shree Hari Chemicals Export Limited to Report Q3, 2024 Results on Feb 14, 2024Shree Hari Chemicals Export Limited announced that they will report Q3, 2024 results on Feb 14, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹1.83 (vs ₹10.91 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹1.83 (up from ₹10.91 loss in 2Q 2023). Revenue: ₹393.5m (up 166% from 2Q 2023). Net income: ₹8.15m (up ₹56.7m from 2Q 2023). Profit margin: 2.1% (up from net loss in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.New Risk • Nov 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.5% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹274.4m market cap, or US$3.29m).お知らせ • Nov 01Shree Hari Chemicals Export Limited to Report Q2, 2024 Results on Nov 08, 2023Shree Hari Chemicals Export Limited announced that they will report Q2, 2024 results on Nov 08, 2023Board Change • Nov 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Non-Executive Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Aug 19Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2023Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2023, at 11:30 Indian Standard Time.Reported Earnings • Aug 18First quarter 2024 earnings released: EPS: ₹0.37 (vs ₹9.03 loss in 1Q 2023)First quarter 2024 results: EPS: ₹0.37 (up from ₹9.03 loss in 1Q 2023). Revenue: ₹296.8m (up 68% from 1Q 2023). Net income: ₹1.65m (up ₹41.8m from 1Q 2023). Profit margin: 0.6% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.New Risk • Jun 08New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 6.5% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.5% operating cash flow to total debt). Earnings have declined by 10% per year over the past 5 years. Market cap is less than US$10m (₹199.0m market cap, or US$2.41m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).お知らせ • May 19Shree Hari Chemicals Export Limited to Report Q4, 2023 Results on May 25, 2023Shree Hari Chemicals Export Limited announced that they will report Q4, 2023 results on May 25, 2023Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹21.76 loss per share (vs ₹2.45 profit in 3Q 2022)Third quarter 2023 results: ₹21.76 loss per share (down from ₹2.45 profit in 3Q 2022). Revenue: ₹394.4m (up 98% from 3Q 2022). Net loss: ₹96.8m (down ₹107.7m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.お知らせ • Feb 03Shree Hari Chemicals Export Limited to Report Q3, 2023 Results on Feb 14, 2023Shree Hari Chemicals Export Limited announced that they will report Q3, 2023 results on Feb 14, 2023Board Change • Nov 16High number of new directorsAdditional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021.お知らせ • Nov 05Shree Hari Chemicals Export Limited to Report Q2, 2023 Results on Nov 14, 2022Shree Hari Chemicals Export Limited announced that they will report Q2, 2023 results on Nov 14, 2022Board Change • Oct 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Aug 19Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 28, 2022Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 28, 2022, at 15:00 Indian Standard Time.お知らせ • Aug 03Shree Hari Chemicals Export Limited to Report Q1, 2023 Results on Aug 10, 2022Shree Hari Chemicals Export Limited announced that they will report Q1, 2023 results on Aug 10, 2022お知らせ • Jul 30Shree Hari Chemicals Export Limited Announces Temporary Halt in Factory OperationsShree Hari Chemicals Export Limited announced temporary halt in the Factory operations due to maintenance of manufacturing unit.Reported Earnings • Jun 02Full year 2022 earnings released: EPS: ₹1.57 (vs ₹1.90 in FY 2021)Full year 2022 results: EPS: ₹1.57 (down from ₹1.90 in FY 2021). Revenue: ₹764.5m (up 36% from FY 2021). Net income: ₹6.78m (down 20% from FY 2021). Profit margin: 0.9% (down from 1.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.お知らせ • May 20Shree Hari Chemicals Export Limited to Report Q4, 2022 Results on May 27, 2022Shree Hari Chemicals Export Limited announced that they will report Q4, 2022 results on May 27, 2022Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹79.60, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 129% over the past three years.Valuation Update With 7 Day Price Move • Feb 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹59.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 81% over the past three years.Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹2.45 (up from ₹2.28 in 3Q 2021). Revenue: ₹203.1m (up 40% from 3Q 2021). Net income: ₹10.9m (up 7.7% from 3Q 2021). Profit margin: 5.4% (down from 7.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 05Shree Hari Chemicals Export Limited to Report Q3, 2022 Results on Feb 14, 2022Shree Hari Chemicals Export Limited announced that they will report Q3, 2022 results on Feb 14, 2022Reported Earnings • Nov 18Second quarter 2022 earnings released: ₹1.37 loss per share (vs ₹1.57 loss in 2Q 2021)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2022 results: Revenue: ₹249.2m (up 206% from 2Q 2021). Net loss: ₹6.10m (loss narrowed 13% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹0.59 (vs ₹5.31 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹91.5m (up 324% from 1Q 2021). Net income: ₹2.62m (up ₹26.2m from 1Q 2021). Profit margin: 2.9% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Executive Departure • Jul 13Additional Independent Director Kishor Kharat has left the companyOn the 1st of July, Kishor Kharat's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Kishor's name. A total of 4 executives have left over the last 12 months.Reported Earnings • Jun 02Full year 2021 earnings released: EPS ₹1.93 (vs ₹3.61 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹569.3m (flat on FY 2020). Net income: ₹8.45m (up ₹24.5m from FY 2020). Profit margin: 1.5% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹54.80, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 4.8% over the past three years.Valuation Update With 7 Day Price Move • Feb 18Investor sentiment improved over the past weekAfter last week's 44% share price gain to ₹50.40, the stock is trading at a trailing P/E ratio of 20.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 17%.Is New 90 Day High Low • Feb 15New 90-day high: ₹41.60The company is up 81% from its price of ₹23.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹2.28 (vs ₹2.76 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹145.1m (down 12% from 3Q 2020). Net income: ₹10.1m (up ₹22.4m from 3Q 2020). Profit margin: 7.0% (up from net loss in 3Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Feb 05Shree Hari Chemicals Export Limited to Report Q3, 2021 Results on Feb 11, 2021Shree Hari Chemicals Export Limited announced that they will report Q3, 2021 results on Feb 11, 2021お知らせ • Jan 29Shree Hari Chemicals Export Ltd. Appoints Shri Kishor Piraji Kharat as Additional Director and Independent Director, with Effect from January 28, 2021Shree Hari Chemicals Export Ltd. announced Appointment of Shri Kishor Piraji Kharat as an Additional Director and Independent Director of the Company with effect from January 28, 2021.Is New 90 Day High Low • Dec 12New 90-day high: ₹35.60The company is up 2.0% from its price of ₹34.85 on 11 September 2020. The Indian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.お知らせ • Nov 25Shree Hari Chemicals Export Limited, Annual General Meeting, Dec 30, 2020Shree Hari Chemicals Export Limited, Annual General Meeting, Dec 30, 2020, at 11:30 Indian Standard Time.Is New 90 Day High Low • Nov 12New 90-day low: ₹23.85The company is down 46% from its price of ₹44.10 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.お知らせ • Nov 05Shree Hari Chemicals Export Limited to Report Q2, 2021 Results on Nov 11, 2020Shree Hari Chemicals Export Limited announced that they will report Q2, 2021 results on Nov 11, 2020お知らせ • Oct 30Shree Hari Chemicals Export Limited Announces Board ChangesShree Hari Chemicals Export Limited announced that the Board of Directors at their Meeting on 29 October, 2020 considered and approved the appointments of Shri Sarthak Agarwal as an Additional Director of the Company with effect from October 29, 2020, Shri Nihit Agarwal of as an Additional Director the Company with effect from October 29, 2020 and Shri Parag Agrawal as an Additional Director and Independent Director of the Company with effect from October 29, 2020 and approved the resignations of Shri Anup Ramuka as Director and Managing Director of the Company with effect from close of business hours on October 29, 2020 due to personal reasons, Shri Arvind Chirania as an Independent Director with effect from close of business hours on October 29, 2020 due to personal reasons and he has also confirmed in his resignation letter that there is no other material reasons for resignation from the Directorship of the Company other than the personal reasons and Shri Vinit Kedia as an Independent Director with effect from close of business hours on October 29, 2020 due to personal reasons and he has also confirmed in his resignation letter that there is no other material reasons for resignation from the Directorship of the Company other than the personal reasons. In view of resignation of Shri Anup Ramuka as Director and Managing Director of the Company, he ceases to be key managerial personnel authorized determining the materiality of event or information and for the purpose of making disclosures to the Stock Exchange pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.お知らせ • Sep 08Shree Hari Chemicals Export Limited to Report Q1, 2021 Results on Sep 14, 2020Shree Hari Chemicals Export Limited announced that they will report Q1, 2021 results on Sep 14, 2020お知らせ • Aug 12Shree Hari Chemicals Export Limited Resumes Manufacturing Activities in Phased MannerWith reference to Shree Hari Chemicals Export Limited earlier intimation dated March 30, 2020 informing about shutdown of Company’s factory located at Mahad in the State of Maharashtra in the light of lockdown related to the COVID-19 pandemic. The company would like to inform that it has resumed its manufacturing activities in a phased manner as per the guideline issued by the District Collector, Raigad time to time.株主還元524336IN ChemicalsIN 市場7D3.4%0.6%-0.4%1Y66.6%1.9%4.6%株主還元を見る業界別リターン: 524336過去 1 年間で1.9 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 524336過去 1 年間で4.6 % の収益を上げたIndian市場を上回りました。価格変動Is 524336's price volatile compared to industry and market?524336 volatility524336 Average Weekly Movement8.2%Chemicals Industry Average Movement6.0%Market Average Movement5.9%10% most volatile stocks in IN Market8.9%10% least volatile stocks in IN Market3.6%安定した株価: 524336の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 524336の weekly volatility ( 8% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1987120Bankesh Agrawalwww.shreeharichemicals.inShree Hari Chemicals Export Limited 社は、H-酸と染料中間体の製造、輸出、供給をインド国内外で行っている。1-アミノ酸、8-ナフトール酸、3-6ジスルホン酸のほか、酸、直接染料、中間体、反応染料を提供。同社は1987年に設立され、インドのムンバイを拠点としている。もっと見るShree Hari Chemicals Export Limited 基礎のまとめShree Hari Chemicals Export の収益と売上を時価総額と比較するとどうか。524336 基礎統計学時価総額₹2.02b収益（TTM）₹117.14m売上高(TTM)₹2.16b17.3xPER（株価収益率0.9xP/Sレシオ524336 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計524336 損益計算書（TTM）収益₹2.16b売上原価₹1.43b売上総利益₹724.94mその他の費用₹607.80m収益₹117.14m直近の収益報告Jun 30, 2026次回決算日該当なし一株当たり利益（EPS）10.35グロス・マージン33.62%純利益率5.43%有利子負債／自己資本比率74.3%524336 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/15 22:08終値2026/08/14 00:00収益2026/06/30年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Shree Hari Chemicals Export Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • 1hFirst quarter 2027 earnings released: EPS: ₹9.41 (vs ₹3.39 loss in 1Q 2026)First quarter 2027 results: EPS: ₹9.41 (up from ₹3.39 loss in 1Q 2026). Revenue: ₹556.3m (up 129% from 1Q 2026). Net income: ₹59.2m (up ₹76.0m from 1Q 2026). Profit margin: 11% (up from net loss in 1Q 2026). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (9.0% average weekly change). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.96b market cap, or US$20.6m).
お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2027 Results on Aug 14, 2026Shree Hari Chemicals Export Limited announced that they will report Q1, 2027 results on Aug 14, 2026
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹164, the stock trades at a trailing P/E ratio of 45.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 260% over the past three years.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹132, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.
New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.6m).
Reported Earnings • 1hFirst quarter 2027 earnings released: EPS: ₹9.41 (vs ₹3.39 loss in 1Q 2026)First quarter 2027 results: EPS: ₹9.41 (up from ₹3.39 loss in 1Q 2026). Revenue: ₹556.3m (up 129% from 1Q 2026). Net income: ₹59.2m (up ₹76.0m from 1Q 2026). Profit margin: 11% (up from net loss in 1Q 2026). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (9.0% average weekly change). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.96b market cap, or US$20.6m).
お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2027 Results on Aug 14, 2026Shree Hari Chemicals Export Limited announced that they will report Q1, 2027 results on Aug 14, 2026
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹164, the stock trades at a trailing P/E ratio of 45.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 260% over the past three years.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹132, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.
New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.6m).
New Risk • May 23New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). High level of non-cash earnings (20% accrual ratio). Shareholders have been substantially diluted in the past year (129% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₹1.27b market cap, or US$13.3m).
Reported Earnings • May 18Full year 2026 earnings released: EPS: ₹7.45 (vs ₹11.41 in FY 2025)Full year 2026 results: EPS: ₹7.45 (down from ₹11.41 in FY 2025). Revenue: ₹1.88b (up 33% from FY 2025). Net income: ₹41.2m (down 19% from FY 2025). Profit margin: 2.2% (down from 3.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
お知らせ • May 08Shree Hari Chemicals Export Limited to Report Fiscal Year 2026 Results on May 15, 2026Shree Hari Chemicals Export Limited announced that they will report fiscal year 2026 results on May 15, 2026
Valuation Update With 7 Day Price Move • May 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹125, the stock trades at a trailing P/E ratio of 45.8x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 178% over the past three years.
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹2.20 (vs ₹5.91 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.20 (down from ₹5.91 in 3Q 2025). Revenue: ₹447.8m (up 15% from 3Q 2025). Net income: ₹12.2m (down 54% from 3Q 2025). Profit margin: 2.7% (down from 6.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 23Shree Hari Chemicals Export Limited to Report Q3, 2026 Results on Jan 31, 2026Shree Hari Chemicals Export Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Jan 31, 2026
New Risk • Dec 06New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 137% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). High level of non-cash earnings (41% accrual ratio). Shareholders have been substantially diluted in the past year (137% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹1.29b market cap, or US$14.3m).
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 37%After last week's 37% share price gain to ₹142, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 163% over the past three years.
お知らせ • Nov 07Shree Hari Chemicals Export Limited to Report Q2, 2026 Results on Nov 14, 2025Shree Hari Chemicals Export Limited announced that they will report Q2, 2026 results on Nov 14, 2025
New Risk • Sep 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). Market cap is less than US$10m (₹495.5m market cap, or US$5.58m). Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).
お知らせ • Aug 18Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2025Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2025, at 15:00 Indian Standard Time.
Reported Earnings • Aug 14First quarter 2026 earnings released: ₹3.39 loss per share (vs ₹0.47 profit in 1Q 2025)First quarter 2026 results: ₹3.39 loss per share (down from ₹0.47 profit in 1Q 2025). Revenue: ₹245.3m (down 21% from 1Q 2025). Net loss: ₹16.7m (down ₹18.8m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 07Shree Hari Chemicals Export Limited to Report Q1, 2026 Results on Aug 13, 2025Shree Hari Chemicals Export Limited announced that they will report Q1, 2026 results on Aug 13, 2025
New Risk • May 31New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹729.0m market cap, or US$8.52m).
Reported Earnings • May 31Full year 2025 earnings released: EPS: ₹11.41 (vs ₹5.16 in FY 2024)Full year 2025 results: EPS: ₹11.41 (up from ₹5.16 in FY 2024). Revenue: ₹1.42b (up 3.2% from FY 2024). Net income: ₹51.0m (up 122% from FY 2024). Profit margin: 3.6% (up from 1.7% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
お知らせ • May 22Shree Hari Chemicals Export Limited to Report Q4, 2025 Results on May 29, 2025Shree Hari Chemicals Export Limited announced that they will report Q4, 2025 results on May 29, 2025
Board Change • Mar 26Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Additional Independent Director Sanjay Gupta was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 25Shree Hari Chemicals Export Limited Announces Cessation of Ekta Sumit Sultania as an Independent DirectorShree Hari Chemicals Export Limited informed that Smt. Ekta Sumit Sultania (DIN: 07134485) retired on completion of her term of office as an Independent Director of the Company on March 25, 2025 and ceased to be the Independent Director of the Company thereafter.
Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹151, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 136% over the past three years.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹124, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.
Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹5.91 (vs ₹2.33 in 3Q 2024)Third quarter 2025 results: EPS: ₹5.91 (up from ₹2.33 in 3Q 2024). Revenue: ₹392.6m (up 6.2% from 3Q 2024). Net income: ₹26.3m (up 154% from 3Q 2024). Profit margin: 6.7% (up from 2.8% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 04Shree Hari Chemicals Export Limited to Report Q3, 2025 Results on Feb 12, 2025Shree Hari Chemicals Export Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Valuation Update With 7 Day Price Move • Dec 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹128, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 113% over the past three years.
Reported Earnings • Nov 13Second quarter 2025 earnings released: EPS: ₹5.05 (vs ₹1.83 in 2Q 2024)Second quarter 2025 results: EPS: ₹5.05 (up from ₹1.83 in 2Q 2024). Revenue: ₹366.6m (down 6.1% from 2Q 2024). Net income: ₹22.4m (up 175% from 2Q 2024). Profit margin: 6.1% (up from 2.1% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹99.26, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years.
お知らせ • Nov 04Shree Hari Chemicals Export Limited to Report Q2, 2025 Results on Nov 12, 2024Shree Hari Chemicals Export Limited announced that they will report Q2, 2025 results on Nov 12, 2024
Buy Or Sell Opportunity • Oct 22Now 20% undervaluedOver the last 90 days, the stock has risen 17% to ₹93.45. The fair value is estimated to be ₹118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Meanwhile, the company has become profitable.
Board Change • Sep 12High number of new directorsAdditional Independent Director Sanjay Gupta was the last director to join the board, commencing their role in 2024.
New Risk • Aug 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Market cap is less than US$10m (₹443.6m market cap, or US$5.29m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
お知らせ • Aug 29Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2024Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2024, at 13:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹99.76, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 66% over the past three years.
お知らせ • Aug 22Shree Hari Chemicals Export Limited announced a financing transactionShree Hari Chemicals Export Limited announced a private placement to issue Compulsorily Convertible Debentures on August 20, 2024. The transaction has been approved by shareholders and is subject to general shareholders of 37 Annual General Meeting of the Company.
お知らせ • Aug 15Shree Hari Chemicals Export Limited Approves the Appointment of Vikas Agarwal as Additional Non- Executive DirectorShree Hari Chemicals Export Limited at its board meeting held on August 12, 2024, based on the recommendation of the Nomination and Remuneration Committee, considered and approved the appointment of Shri Vikas Agarwal as an Additional Non- Executive Director of the Company with effect from August 12, 2024 who shall hold office up to the date of the upcoming Annual General Meeting of the Company. Shri Vikas Agarwal is a MBA and Commerce Graduate with over 20 years of experience in polyester business.
Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: ₹0.47 (vs ₹0.37 in 1Q 2024)First quarter 2025 results: EPS: ₹0.47 (up from ₹0.37 in 1Q 2024). Revenue: ₹310.0m (up 5.5% from 1Q 2024). Net income: ₹2.08m (up 27% from 1Q 2024). Profit margin: 0.7% (up from 0.6% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Aug 05Shree Hari Chemicals Export Limited to Report Q1, 2025 Results on Aug 12, 2024Shree Hari Chemicals Export Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹89.21, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 24% over the past three years.
Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹5.16 (vs ₹44.54 loss in FY 2023)Full year 2024 results: EPS: ₹5.16 (up from ₹44.54 loss in FY 2023). Revenue: ₹1.43b (up 39% from FY 2023). Net income: ₹22.9m (up ₹221.0m from FY 2023). Profit margin: 1.6% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • May 20Shree Hari Chemicals Export Limited to Report Q4, 2024 Results on May 27, 2024Shree Hari Chemicals Export Limited announced that they will report Q4, 2024 results on May 27, 2024
Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹99.34, the stock trades at a trailing P/E ratio of 58.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 62% over the past three years.
Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹2.33 (vs ₹21.76 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹2.33 (up from ₹21.76 loss in 3Q 2023). Revenue: ₹372.9m (down 4.8% from 3Q 2023). Net income: ₹10.4m (up ₹107.1m from 3Q 2023). Profit margin: 2.8% (up from net loss in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 07Shree Hari Chemicals Export Limited to Report Q3, 2024 Results on Feb 14, 2024Shree Hari Chemicals Export Limited announced that they will report Q3, 2024 results on Feb 14, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹1.83 (vs ₹10.91 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹1.83 (up from ₹10.91 loss in 2Q 2023). Revenue: ₹393.5m (up 166% from 2Q 2023). Net income: ₹8.15m (up ₹56.7m from 2Q 2023). Profit margin: 2.1% (up from net loss in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.
New Risk • Nov 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.5% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹274.4m market cap, or US$3.29m).
お知らせ • Nov 01Shree Hari Chemicals Export Limited to Report Q2, 2024 Results on Nov 08, 2023Shree Hari Chemicals Export Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Board Change • Nov 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Non-Executive Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 19Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2023Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 27, 2023, at 11:30 Indian Standard Time.
Reported Earnings • Aug 18First quarter 2024 earnings released: EPS: ₹0.37 (vs ₹9.03 loss in 1Q 2023)First quarter 2024 results: EPS: ₹0.37 (up from ₹9.03 loss in 1Q 2023). Revenue: ₹296.8m (up 68% from 1Q 2023). Net income: ₹1.65m (up ₹41.8m from 1Q 2023). Profit margin: 0.6% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
New Risk • Jun 08New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 6.5% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.5% operating cash flow to total debt). Earnings have declined by 10% per year over the past 5 years. Market cap is less than US$10m (₹199.0m market cap, or US$2.41m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).
お知らせ • May 19Shree Hari Chemicals Export Limited to Report Q4, 2023 Results on May 25, 2023Shree Hari Chemicals Export Limited announced that they will report Q4, 2023 results on May 25, 2023
Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹21.76 loss per share (vs ₹2.45 profit in 3Q 2022)Third quarter 2023 results: ₹21.76 loss per share (down from ₹2.45 profit in 3Q 2022). Revenue: ₹394.4m (up 98% from 3Q 2022). Net loss: ₹96.8m (down ₹107.7m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
お知らせ • Feb 03Shree Hari Chemicals Export Limited to Report Q3, 2023 Results on Feb 14, 2023Shree Hari Chemicals Export Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Board Change • Nov 16High number of new directorsAdditional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021.
お知らせ • Nov 05Shree Hari Chemicals Export Limited to Report Q2, 2023 Results on Nov 14, 2022Shree Hari Chemicals Export Limited announced that they will report Q2, 2023 results on Nov 14, 2022
Board Change • Oct 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 19Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 28, 2022Shree Hari Chemicals Export Limited, Annual General Meeting, Sep 28, 2022, at 15:00 Indian Standard Time.
お知らせ • Aug 03Shree Hari Chemicals Export Limited to Report Q1, 2023 Results on Aug 10, 2022Shree Hari Chemicals Export Limited announced that they will report Q1, 2023 results on Aug 10, 2022
お知らせ • Jul 30Shree Hari Chemicals Export Limited Announces Temporary Halt in Factory OperationsShree Hari Chemicals Export Limited announced temporary halt in the Factory operations due to maintenance of manufacturing unit.
Reported Earnings • Jun 02Full year 2022 earnings released: EPS: ₹1.57 (vs ₹1.90 in FY 2021)Full year 2022 results: EPS: ₹1.57 (down from ₹1.90 in FY 2021). Revenue: ₹764.5m (up 36% from FY 2021). Net income: ₹6.78m (down 20% from FY 2021). Profit margin: 0.9% (down from 1.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
お知らせ • May 20Shree Hari Chemicals Export Limited to Report Q4, 2022 Results on May 27, 2022Shree Hari Chemicals Export Limited announced that they will report Q4, 2022 results on May 27, 2022
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹79.60, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 129% over the past three years.
Valuation Update With 7 Day Price Move • Feb 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹59.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 81% over the past three years.
Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹2.45 (up from ₹2.28 in 3Q 2021). Revenue: ₹203.1m (up 40% from 3Q 2021). Net income: ₹10.9m (up 7.7% from 3Q 2021). Profit margin: 5.4% (down from 7.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 05Shree Hari Chemicals Export Limited to Report Q3, 2022 Results on Feb 14, 2022Shree Hari Chemicals Export Limited announced that they will report Q3, 2022 results on Feb 14, 2022
Reported Earnings • Nov 18Second quarter 2022 earnings released: ₹1.37 loss per share (vs ₹1.57 loss in 2Q 2021)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2022 results: Revenue: ₹249.2m (up 206% from 2Q 2021). Net loss: ₹6.10m (loss narrowed 13% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Shri Gupta was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹0.59 (vs ₹5.31 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹91.5m (up 324% from 1Q 2021). Net income: ₹2.62m (up ₹26.2m from 1Q 2021). Profit margin: 2.9% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Executive Departure • Jul 13Additional Independent Director Kishor Kharat has left the companyOn the 1st of July, Kishor Kharat's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Kishor's name. A total of 4 executives have left over the last 12 months.
Reported Earnings • Jun 02Full year 2021 earnings released: EPS ₹1.93 (vs ₹3.61 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹569.3m (flat on FY 2020). Net income: ₹8.45m (up ₹24.5m from FY 2020). Profit margin: 1.5% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹54.80, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 4.8% over the past three years.
Valuation Update With 7 Day Price Move • Feb 18Investor sentiment improved over the past weekAfter last week's 44% share price gain to ₹50.40, the stock is trading at a trailing P/E ratio of 20.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 17%.
Is New 90 Day High Low • Feb 15New 90-day high: ₹41.60The company is up 81% from its price of ₹23.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹2.28 (vs ₹2.76 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹145.1m (down 12% from 3Q 2020). Net income: ₹10.1m (up ₹22.4m from 3Q 2020). Profit margin: 7.0% (up from net loss in 3Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Feb 05Shree Hari Chemicals Export Limited to Report Q3, 2021 Results on Feb 11, 2021Shree Hari Chemicals Export Limited announced that they will report Q3, 2021 results on Feb 11, 2021
お知らせ • Jan 29Shree Hari Chemicals Export Ltd. Appoints Shri Kishor Piraji Kharat as Additional Director and Independent Director, with Effect from January 28, 2021Shree Hari Chemicals Export Ltd. announced Appointment of Shri Kishor Piraji Kharat as an Additional Director and Independent Director of the Company with effect from January 28, 2021.
Is New 90 Day High Low • Dec 12New 90-day high: ₹35.60The company is up 2.0% from its price of ₹34.85 on 11 September 2020. The Indian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
お知らせ • Nov 25Shree Hari Chemicals Export Limited, Annual General Meeting, Dec 30, 2020Shree Hari Chemicals Export Limited, Annual General Meeting, Dec 30, 2020, at 11:30 Indian Standard Time.
Is New 90 Day High Low • Nov 12New 90-day low: ₹23.85The company is down 46% from its price of ₹44.10 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
お知らせ • Nov 05Shree Hari Chemicals Export Limited to Report Q2, 2021 Results on Nov 11, 2020Shree Hari Chemicals Export Limited announced that they will report Q2, 2021 results on Nov 11, 2020
お知らせ • Oct 30Shree Hari Chemicals Export Limited Announces Board ChangesShree Hari Chemicals Export Limited announced that the Board of Directors at their Meeting on 29 October, 2020 considered and approved the appointments of Shri Sarthak Agarwal as an Additional Director of the Company with effect from October 29, 2020, Shri Nihit Agarwal of as an Additional Director the Company with effect from October 29, 2020 and Shri Parag Agrawal as an Additional Director and Independent Director of the Company with effect from October 29, 2020 and approved the resignations of Shri Anup Ramuka as Director and Managing Director of the Company with effect from close of business hours on October 29, 2020 due to personal reasons, Shri Arvind Chirania as an Independent Director with effect from close of business hours on October 29, 2020 due to personal reasons and he has also confirmed in his resignation letter that there is no other material reasons for resignation from the Directorship of the Company other than the personal reasons and Shri Vinit Kedia as an Independent Director with effect from close of business hours on October 29, 2020 due to personal reasons and he has also confirmed in his resignation letter that there is no other material reasons for resignation from the Directorship of the Company other than the personal reasons. In view of resignation of Shri Anup Ramuka as Director and Managing Director of the Company, he ceases to be key managerial personnel authorized determining the materiality of event or information and for the purpose of making disclosures to the Stock Exchange pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
お知らせ • Sep 08Shree Hari Chemicals Export Limited to Report Q1, 2021 Results on Sep 14, 2020Shree Hari Chemicals Export Limited announced that they will report Q1, 2021 results on Sep 14, 2020
お知らせ • Aug 12Shree Hari Chemicals Export Limited Resumes Manufacturing Activities in Phased MannerWith reference to Shree Hari Chemicals Export Limited earlier intimation dated March 30, 2020 informing about shutdown of Company’s factory located at Mahad in the State of Maharashtra in the light of lockdown related to the COVID-19 pandemic. The company would like to inform that it has resumed its manufacturing activities in a phased manner as per the guideline issued by the District Collector, Raigad time to time.
